Wolfgang Künnecke
Vice President of Bioanalytics • 908 Devices
Wolfgang Künnecke is the Vice President of Bioanalytics at 908 Devices. He founded and served as CEO of TRACE Analytics, the first manufacturer in the world to offer a continuous enzymatic based monitoring of bioreactors, until it was acquired by 908 Devices in August 2022. Wolfgang has more than 25 years of experience in online monitoring of bioprocesses, specializing in biosensors that offer continuous measurement of glucose and lactate. He holds a Ph.D in biotechnology and biosensors from the German Research Centre for Biotechnology (now the Helmholtz Centre for Infection Research) in Braunschweig, Germany.
Also Speaking
Carl H. June
Director of the Center for Cellular Immunotherapies at the Perelman School of Medicine • University of Pennsylvania
18 November 2022
Also Speaking
Investor List
Take a look at some of the investors who attended Advanced Therapies Week 2023.
6 January 2023
